Company Rekah Pharmaceutical Industry Ltd. TEL AVIV STOCK EXCHANGE
Equities
REKA
IL0010810096
Pharmaceuticals
Business Summary
Sales per Business
ILS in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Core Products
64.8
%
| 161 | 60.9 % | 190 | 64.8 % | +17.90% |
Distribution Special
29.8
%
| 88 | 33.5 % | 87 | 29.8 % | -1.33% |
Other
5.4
%
| 15 | 5.6 % | 16 | 5.4 % | +5.64% |
Sales per region
ILS in Million | 2021 | Weight | 2022 | Weight | Delta |
---|---|---|---|---|---|
Israel
100.0
%
| 264 | 100.0 % | 292 | 100.0 % | +10.78% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 80 | 23/08/93 | |
Yuval Bernshtein
DFI | Director of Finance/CFO | 44 | 31/10/18 |
Director/Board Member | 78 | 23/08/93 | |
Jack Azran
PRN | Corporate Officer/Principal | - | - |
Guy Zangi
SAM | Sales & Marketing | 51 | 12/09/18 |
Yuval Elgrably
PRN | Corporate Officer/Principal | 47 | 30/03/11 |
Ronit Zelnik
PRN | Corporate Officer/Principal | 66 | 08/01/97 |
Joseph Ginossar
AUD | Comptroller/Controller/Auditor | 65 | 14/06/14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Ishay Davidi
BRD | Director/Board Member | 62 | 14/04/15 |
Amiram Boehm
BRD | Director/Board Member | 52 | 14/04/15 |
Avraham Bigger
CHM | Chairman | 77 | 14/04/15 |
Chief Executive Officer | 80 | 23/08/93 | |
Director/Board Member | 78 | 23/08/93 | |
Orly Silberman
BRD | Director/Board Member | 64 | 14/04/15 |
Udi Nissan Nisan
BRD | Director/Board Member | 55 | 31/10/16 |
Arnon Zuaretz
BRD | Director/Board Member | 70 | 31/10/16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 11,523,922 | 2,000,627 ( 17.36 %) | 19,900 ( 0.1727 %) | 17.36 % |
Company contact information
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
-1.88% | 24.09B | |
+7.11% | 8.2B | |
-20.55% | 7.97B | |
-0.98% | 7.84B | |
+1.95% | 4.66B | |
+17.12% | 4.32B | |
+1.41% | 4.19B | |
-3.02% | 3.89B | |
+21.42% | 3.62B |